Hidradenitis suppurativa

Barth JH , Kealey T. Androgen metabolism by isolated human axillary apocrine glands in hidradenitis suppurativa. Br J Dermatol 1991; 125: 304–8.

Farrell AM , Randall VA , Vafaee T , Dawber RP. Finasteride as a therapy for hidradenitis suppurativa. Br J Dermatol 1999; 141: 1138–9.

Lewis F , Messenger AG , Wales JKH. Hidradenitis suppurativa as a presenting feature of premature adrenarche. Br J Dermatol 1993; 129: 447–8.

Harrison BJ , Read GF , Hughes LE. Endocrine basis for the clinical presentation of hidradenitis suppurativa. Br J Surg 1988; 75: 972–5.

Mortimer PS , Dawber RP , Gales MA , Moore RA. Mediation of hidradenitis suppurativa by androgens. BMJ 1986; 292: 245–8.

Barth JH , Layton AM , Cunliffe WJ. Endocrine factors in pre- and postmenopausal women with hidradenitis suppurativa. Br J Dermatol 1996; 134: 1057–9.

Sawers RS , Randall VA , Ebling FJG. Control of hidradenitis suppurativa in women using combined antiandrogen (cyproterone acetate) and oestrogen therapy. Br J Dermatol 1985; 115: 269–74.

Mortimer PS , Dawber RPR , Gales MA , Moore RA. A double-blind controlled cross-over trial of cyproterone acetate in females with hidradenitis suppurativa. Br J Dermatol 1986; 115: 263–8.